Argus
•
May 27, 2026
Zimmer Biomet Holdings, Inc.: M&A and robotics drive long-term growth
Summary
Based in Warsaw, Indiana, Zimmer Biomet is the nation's largest pure-play maker of orthopedic devices. The current company arose from the 2015 merger of Zimmer and Biomet, both of which were headquartered in Warsaw, Indiana.
The company designs, develops, and manufactures reconstructive orthopedic implants, sports injury repair and trauma products, and related orthopedic surgical products. Its primary customers include musculoskeletal surgeons, neurosur
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Mettler-Toledo International Inc.
May 28, 2026
•
MTD
The Argus Sustainable Growth Theme Model Portfolio
May 28, 2026
•
TT, GOOGL, DE, AAPL, NDAQ, AVGO, JPM, ADI, MRK, JNJ, TXN, MSFT, TFC, GLW, MA, LLY, TRV, SPGI, GE, NVDA, NOC, KO, KMI, AEP, GS, ECL, TMUS, AMZN, ETN, WMT
Market Digest: LOW, APTV, ZTS
May 27, 2026
•
LOW, ZTS, APTV
Analyst Report: Zoetis Inc
May 27, 2026
•
ZTS
GMED: Raising target price to $94.00
May 27, 2026
•
GMED
Analyst Profile
David H. Toung
Senior Analyst: Medical Devices & Healthcare Services
David covers the Pharmaceutical, Medical Devices, and Healthcare services sectors for Argus. He has more than two decades of experience in the financial analysis industry, having worked for McDonald & Co., JPMorgan Chase and Standard & Poor's, among others. His commentary has appeared on CNBC and in The New York Times. Prior to his financial career, David was a private practice attorney in New Jersey, and served as a Judicial Clerk for an Appellate Division judge in the New Jersey Superior Court. David has a law degree from Rutgers University, where he was a member of the Law Review. He has a B.A. degree in Government from Cornell University. He has passed Level II of the Chartered Financial Analyst examination.
